Glucocorticoid Receptor Deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
104
|
12
|
0.800 |
strong |
0.953 |
86 |
10
|
1991 |
2020 |
Depressive disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1719
|
297
|
0.600 |
None |
0.800 |
65 |
1
|
1999 |
2020 |
Mental Depression
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1478
|
271
|
0.600 |
None |
0.800 |
62 |
1
|
1999 |
2020 |
Depressed mood
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1461
|
269
|
0.100 |
None |
0.984 |
61 |
1
|
1999 |
2020 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.966 |
58 |
2
|
1985 |
2020 |
Major Depressive Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1236
|
1451
|
0.400 |
None |
1.000 |
40 |
10
|
2006 |
2020 |
Unipolar Depression
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
641
|
225
|
0.600 |
None |
1.000 |
26 |
2
|
2004 |
2020 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.400 |
None |
1.000 |
22 |
|
1997 |
2020 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.100 |
None |
1.000 |
21 |
|
1997 |
2020 |
Cushing Syndrome
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
126
|
9
|
0.300 |
None |
1.000 |
19 |
6
|
2000 |
2020 |
Depressive Symptoms
|
phenotype |
Behavior and Behavior Mechanisms
|
Sign or Symptom
|
421
|
120
|
0.100 |
None |
1.000 |
14 |
4
|
2009 |
2020 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.100 |
None |
0.857 |
14 |
1
|
1988 |
2020 |
Adrenal Cushing's syndrome
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
120
|
9
|
0.100 |
None |
1.000 |
13 |
6
|
2000 |
2020 |
Multiple Myeloma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Neoplastic Process
|
1740
|
865
|
0.100 |
None |
1.000 |
11 |
|
1992 |
2020 |
Impaired glucose tolerance
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
596
|
81
|
0.050 |
None |
1.000 |
5 |
|
2008 |
2020 |
Neurodegenerative Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
1515
|
85
|
0.030 |
None |
1.000 |
3 |
|
2015 |
2020 |
Impulsive Behavior
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
276
|
69
|
0.030 |
None |
1.000 |
3 |
|
2013 |
2020 |
Memory impairment
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
763
|
48
|
0.030 |
None |
1.000 |
3 |
|
2018 |
2020 |
Visceral Pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
58
|
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2020 |
Depression, Postpartum
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Mental Disorders
|
Mental or Behavioral Dysfunction
|
54
|
6
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2020 |
Psychiatric symptom
|
phenotype |
|
Sign or Symptom
|
95
|
12
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2020 |
Forgetful
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Sign or Symptom
|
429
|
18
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2020 |
Hyperalgesia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
451
|
4
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2020 |
Hepatitis B, Chronic
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
415
|
84
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2020 |
Salivary duct carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
54
|
9
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |